Forty Years Studied, Nowhere Replicated

Aravind Eye Care System performs more eye surgeries than any organization on Earth — over 500,000 per year — at costs 1/50th of comparable US facilities, with clinical outcomes equal to or better than UK NHS benchmarks. The model has been intensively studied by Harvard Business School, Stanford, and dozens of management researchers. LAICO, Aravind's own training institute, has trained teams from over 60 countries. Yet successful replications are extraordinarily rare. LV Prasad Eye Institute (India) and Tilganga Institute (Nepal) have adapted elements, but no organization outside the Aravind system has achieved comparable volume, cost, and quality simultaneously. The model is visible, documented, taught — and almost entirely non-transferable.

WHO estimates 1 billion people have preventable vision impairment, with 90% in low- and middle-income countries. Cataract alone blinds 17 million people, most of whom could be treated with a 15-minute surgery costing under $25 in the Aravind system. If Aravind's model could be replicated in 20 high-burden countries, the global cataract blindness backlog could be eliminated within a decade. Instead, the model sits as a single-point success — proving feasibility while highlighting the inability to transfer that feasibility. Every year the model is not replicated, approximately 2 million additional people become unnecessarily blind.

LAICO has run hundreds of training programs, and external organizations have attempted to replicate specific elements: high-volume surgery protocols, assembly-line patient flow, cross-subsidization pricing, and vertically integrated lens manufacturing. These element-by-element transfers consistently fail because Aravind's model is not a collection of separable techniques — it is a tightly coupled system where cultural norms, workflow design, workforce training, and organizational mission reinforce each other. Attempting to adopt high-volume surgery without Aravind's specific nurse-to-surgeon workflow doubles complication rates. Cross-subsidization works because Aravind's paying patients choose Aravind despite cheaper alternatives — a trust relationship built over decades that new entrants cannot import. The McDonaldization metaphor (standardized, replicable processes) that management researchers apply to Aravind misidentifies what makes it work: it's not the process standardization, it's the organizational culture that sustains process discipline without bureaucratic enforcement.

Understanding which elements of the Aravind model are genuinely context-specific (founding family's mission culture, Tamil Nadu's specific referral patterns, decades of trust accumulation) versus which could be adapted with appropriate institutional design. Tilganga Institute's partial success suggests that a strong founding leader with clinical and organizational authority, operating within a supportive regulatory environment, can replicate core elements. The replication problem may be less about technical knowledge transfer and more about institutional conditions: what governance structures, incentive alignments, and workforce development pathways enable a healthcare organization to sustain high-volume, low-cost delivery without degradation? This is an organizational design question, not a clinical technique question.

A management team could conduct a structured comparison of Aravind, LV Prasad, Tilganga, and 3–4 failed replication attempts to identify which model elements predicted success or failure. A design team could prototype the minimum viable institutional structure — governance, workforce, workflow, pricing — that captures Aravind's core mechanisms without requiring its 40-year cultural foundation. A health economics team could model the financial sustainability of Aravind-style cross-subsidization in different country contexts (urban/rural ratios, income distributions, insurance coverage levels) to identify where the model's economics are feasible and where they are not.